Results 241 to 250 of about 28,373,227 (361)

New Products: New Products [PDF]

Analytical Chemistry, 2004
openaire   +1 more source

New Chemical Biology Approaches for Engineering Natural Product Assembly Lines.

, 2014
Zhixia Ye
openalex   +1 more source

NEW PRODUCT DEVELOPMENT TEAM CAPABILITIES: a bibliometric review

Santos Arthur, Rafael Morais Pereira
openalex   +1 more source

Nonovert disseminated intravascular coagulation (DIC) in pregnancy: a new scoring system for the identification of patients at risk for obstetrical hemorrhage requiring blood product transfusion

, 2020
Ali Alhousseini, Roberto Romero, Neta Benshalom-Tirosh, Dereje W. Gudicha, Percy Pacora, Dan Tirosh, Doron Kabiri, Lami Yeo, Jecko Thachil, Chaur‐Dong Hsu, Sonia S. Hassan, Offer Erez   +11 more
openalex   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon, Peter T. Gallagher, Orly I. Richter, Neermala Poudel Neupane, Amy C. Mandigo, Jennifer J. McCann, Emanuela Dylgjeri, Irina Vasilevskaya, Christopher McNair, Channing J. Paller, Wm. Kevin Kelly, Karen E. Knudsen, Matthew J. Schiewer, Ayesha A. Shafi   +13 more
wiley   +1 more source

Optimizing working capital during the new product development ramp-up process

, 2019
Saarinen, Henri
openalex   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

Global evaluation of new GRACE mascon products for hydrologic applications

, 2016
B. Scanlon, Zizhan Zhang, H. Save, D. Wiese, F. Landerer, D. Long, L. Longuevergne, Jianli Chen   +7 more
semanticscholar   +1 more source

A new mathematical model for relative quantification in real-time RT-PCR.

Nucleic Acids Research, 2001
M. Pfaffl
semanticscholar   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source